About Bio Farmag Limited

Bio Farmag is working to develop a world-first innovative test for the detection of breast cancer using hair. The breakthrough technology that underpins the Bio Farmag™ Test is the discovery by an Australian scientist that breast cancer can potentially be detected by synchrotron x-ray diffraction of hair. The test is non-invasive and suitable for women from as early as 20 years of age. It may provide early detection of breast cancer thus assist in early treatment. Early detection benefits range from increased survival, increased treatment options and improved quality of life. The Bio Farmag™ Test is in trial and not yet available commercially.

The Team

The Bio Farmag Management team has extensive experience in the establishment of new businesses, the management of public companies in the Service and Health Industries and is supported internationally with a strong scientific team.

 

David Young - Managing Director

Leon Carr - Corporate Strategist  

Richard Toltz - General Counsel

Greg West - Chief Financial Officer & Company Secretary

Dr Peter French - Science & Innovation Manager

Gary Corino - Chief Scientist USA

Diane Collington - General Manager Sales & Marketing

David McClean - General Manager Logistics & Information Technology

Renae Lopez - Medical Liaison Officer

 


Team Chart

 

top